JP2023504166A5 - - Google Patents
Info
- Publication number
- JP2023504166A5 JP2023504166A5 JP2022532695A JP2022532695A JP2023504166A5 JP 2023504166 A5 JP2023504166 A5 JP 2023504166A5 JP 2022532695 A JP2022532695 A JP 2022532695A JP 2022532695 A JP2022532695 A JP 2022532695A JP 2023504166 A5 JP2023504166 A5 JP 2023504166A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- drug
- aforementioned
- dose
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962945093P | 2019-12-06 | 2019-12-06 | |
| US62/945,093 | 2019-12-06 | ||
| US201962948010P | 2019-12-13 | 2019-12-13 | |
| US62/948,010 | 2019-12-13 | ||
| PCT/US2020/063471 WO2021113757A1 (en) | 2019-12-06 | 2020-12-04 | Use of a kv7 potassium channel opener for treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504166A JP2023504166A (ja) | 2023-02-01 |
| JP2023504166A5 true JP2023504166A5 (https=) | 2023-12-12 |
Family
ID=73856375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532695A Pending JP2023504166A (ja) | 2019-12-06 | 2020-12-04 | 疼痛の治療のためのＫｖ７カリウムチャネル開口薬の使用 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP4069211A1 (https=) |
| JP (1) | JP2023504166A (https=) |
| KR (1) | KR20220113411A (https=) |
| CN (1) | CN114786658A (https=) |
| AU (1) | AU2020397173A1 (https=) |
| BR (1) | BR112022010733A2 (https=) |
| CA (1) | CA3159436A1 (https=) |
| CL (1) | CL2022001477A1 (https=) |
| CR (1) | CR20220318A (https=) |
| IL (1) | IL293504A (https=) |
| MX (1) | MX2022006877A (https=) |
| PE (1) | PE20221169A1 (https=) |
| TW (1) | TW202133847A (https=) |
| WO (1) | WO2021113757A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110511220B (zh) | 2018-05-22 | 2022-04-01 | 上海挚盟医药科技有限公司 | 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用 |
| CA3151863C (en) * | 2021-10-27 | 2024-01-02 | Shanghai Zhimeng Biopharma, Inc. | Compound as potassium channel regulator and preparation and use thereof |
| CN113698345B (zh) * | 2021-10-27 | 2022-02-01 | 上海挚盟医药科技有限公司 | 作为钾通道调节剂的化合物及其制备和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9915414D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Medical use |
| US7553858B2 (en) * | 2003-12-17 | 2009-06-30 | Meda Pharma Gmbh & Co. Kg | Combination of flupirtine and tramadol |
| SG174095A1 (en) * | 2006-08-23 | 2011-09-29 | Valeant Pharmaceuticals Int | Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
| WO2013067591A1 (en) * | 2011-11-10 | 2013-05-16 | Relevare Australia Pty Ltd | Topical formulations for pain management |
| US9248122B2 (en) * | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
| WO2019217924A1 (en) * | 2018-05-11 | 2019-11-14 | Xenon Pharmaceuticals Inc. | Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opener |
-
2020
- 2020-12-04 CN CN202080084722.3A patent/CN114786658A/zh active Pending
- 2020-12-04 PE PE2022001015A patent/PE20221169A1/es unknown
- 2020-12-04 MX MX2022006877A patent/MX2022006877A/es unknown
- 2020-12-04 TW TW109142937A patent/TW202133847A/zh unknown
- 2020-12-04 WO PCT/US2020/063471 patent/WO2021113757A1/en not_active Ceased
- 2020-12-04 CR CR20220318A patent/CR20220318A/es unknown
- 2020-12-04 BR BR112022010733A patent/BR112022010733A2/pt not_active Application Discontinuation
- 2020-12-04 KR KR1020227021509A patent/KR20220113411A/ko active Pending
- 2020-12-04 EP EP20828491.9A patent/EP4069211A1/en active Pending
- 2020-12-04 JP JP2022532695A patent/JP2023504166A/ja active Pending
- 2020-12-04 AU AU2020397173A patent/AU2020397173A1/en active Pending
- 2020-12-04 CA CA3159436A patent/CA3159436A1/en active Pending
- 2020-12-04 IL IL293504A patent/IL293504A/en unknown
-
2022
- 2022-06-03 CL CL2022001477A patent/CL2022001477A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6248789B1 (en) | Administration of ketamine to manage pain and to reduce drug dependency | |
| CN1468111A (zh) | 治疗急性、慢性疼痛和/或神经病性疼痛和偏头痛的药物组合物 | |
| JP2023504166A5 (https=) | ||
| RU2004137091A (ru) | Применение соединений, которые являются эффективными как селективные модуляторы опиатного рецептора | |
| US6538008B1 (en) | Combination of a selective NMDA NR2B antagonist and an opioid analgesic | |
| US20040248964A1 (en) | Analgesic uses of norketamine and ketamine/norketamine prodrugs | |
| JP2009073842A (ja) | 苦痛を管理しおよび薬物依存性を軽減するための、ケタミンの投与 | |
| JP2006514056A (ja) | ベンズアミド化合物を使用する痛みおよび外傷性傷害の処置方法ならびにベンズアミド化合物を含有する組成物 | |
| WO2004064753A3 (en) | Use of n-desmethylclozapine to treat human neuropsychiatric disease | |
| US6979689B2 (en) | Compositions and methods for treating upper respiratory congestion | |
| EA002554B1 (ru) | Применение кабэрголина при лечении синдрома усталых ног | |
| WO2013063263A1 (en) | Pharmaceutical compositions for treating pain | |
| IL315023A (en) | Neuroactive steroids for treatment of cns-related disorders | |
| JP2007517049A (ja) | 再発性病状を治療するための組成物および方法 | |
| CA2468314A1 (en) | The use of water-soluble lamarin in the treatment of cancer | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| CA2403994A1 (en) | Nasal administration of agents for the treatment of gastroparesis | |
| JP2023504166A (ja) | 疼痛の治療のためのＫｖ７カリウムチャネル開口薬の使用 | |
| US20110008431A1 (en) | Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia | |
| NO309965B1 (no) | Oralt farmasøytisk antihostepreparat | |
| US20080132531A1 (en) | Synergistic combinations of norketamine and opioid analgesics | |
| US20140148465A1 (en) | Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine | |
| CA2576926A1 (en) | Use of midostaurin for treating gastrointestinal stromal tumors | |
| HK1058899A (en) | A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines | |
| RU2002128958A (ru) | Способ лечения онкологических больных |